Latest stories on CRVO
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CervoMed Completes Enrollment in Phase 2a Neflamapimod Trial
TipRanks63 · neutralproduct/pr
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CervoMed’s DLB Trial Milestone: What CRVO Investors Should Watch Next
TipRanks58 · neutralproduct/pr
CervoMed Raises $10 Million in Direct Offering
TipRanks24 · bearishgeneral
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CRVO Stock Rockets Nearly 100% On Patent Win Before Offering News Cools Rally
Stocktwits News67 · bullishproduct/pr
CervoMed Bolsters Patent Shield on Neflamapimod—IP Protection for Pure Dementia with Lewy Bodies Now Extends to 2042
MarketChameleon67 · bullishproduct/pr
CervoMed Secures U.S. Patent for Neflamapimod in Pure Dementia with Lewy Bodies—A New Chapter in Neurodegenerative Research
MarketChameleon63 · neutralproduct/pr
CervoMed Gains New Patent for Neflamapimod Dementia Therapy
TipRanks63 · neutralproduct/pr
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CRVO Showcases Investor Optimism as Clinical Milestones Highlight Path to Phase 3
MarketChameleon67 · bullishproduct/pr
CervoMed Posts Updated Investor Presentation and Business Overview
TipRanks55 · neutralgeneral
CervoMed Inc. (CRVO) files 8-K
SEC 8-K50 · neutralgeneral
CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit | CRVO Stock News
StockTitan55 · neutralgeneral
Why Did CRVO Stock Crash 22% In Pre-Market Trading Today?
Stocktwits News24 · bearishgeneral
CervoMed Announces Private Placement to Advance Neurology Pipeline
TipRanks24 · bearishgeneral